Sucampo Pharma (SCMP) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update
November 4, 2015 6:30 AM ESTAMITIZA Revenue Performance Drives Income Growth
R-Tech Ueno Tender Offer Achieved Threshold; Sucampo Closed on Debt Financing
Company Reiterates 2015 Earnings Guidance
Company to Host Conference Call Today at 8:30 a.m. EST
ROCKVILLE, Md., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the third quarter ended September 30, 2015.
For the three months ended September 30,... More
Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update
November 4, 2015 6:30 AM ESTAMITIZA Revenue Performance Drives Income Growth
R-Tech Ueno Tender Offer Achieved Threshold; Sucampo Closed on Debt Financing
Company Reiterates 2015 Earnings Guidance
Company to Host Conference Call Today at 8:30 a.m. EST
ROCKVILLE, Md., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the third quarter ended September 30, 2015.
For the three months ended September 30,... More
